204 related articles for article (PubMed ID: 1983324)
1. Maintenance therapy of duodenal ulcer with H2-receptor antagonists--a meta-analysis.
Palmer RH; Frank WO; Karlstadt R
Aliment Pharmacol Ther; 1990 Jun; 4(3):283-94. PubMed ID: 1983324
[TBL] [Abstract][Full Text] [Related]
2. [Inhibition of 24-hour acidity by nizatidine].
Dammann HG; Dreyer M; Gottlieb WR; Wolf N; Müller P; Simon B
Fortschr Med; 1989 May; 107(14):321-4. PubMed ID: 2568971
[TBL] [Abstract][Full Text] [Related]
3. Clinical review of histamine2 receptor antagonists.
Lipsy RJ; Fennerty B; Fagan TC
Arch Intern Med; 1990 Apr; 150(4):745-51. PubMed ID: 1970232
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
Poynard T; Lemaire M; Agostini H
Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):661-5. PubMed ID: 8590162
[TBL] [Abstract][Full Text] [Related]
5. Single nocturnal dose of an H2 receptor antagonist for the treatment of duodenal ulcer.
Gledhill T; Howard OM; Buck M; Paul A; Hunt RH
Gut; 1983 Oct; 24(10):904-8. PubMed ID: 6311692
[TBL] [Abstract][Full Text] [Related]
6. Famotidine in the treatment of gastric and duodenal ulceration: overview of clinical experience.
Bianchi Porro G
Digestion; 1985; 32 Suppl 1():62-9. PubMed ID: 2866137
[TBL] [Abstract][Full Text] [Related]
7. H2-receptor antagonists and duodenal ulcer recurrence: analysis of efficacy and commentary on safety, costs, and patient selection.
Freston JW
Am J Gastroenterol; 1987 Dec; 82(12):1242-9. PubMed ID: 2891294
[TBL] [Abstract][Full Text] [Related]
8. Morning versus evening dose: a comparison of three H2-receptor blockers in duodenal ulcer healing.
Khasawneh SM; Affarah HB
Am J Gastroenterol; 1992 Sep; 87(9):1180-2. PubMed ID: 1519576
[TBL] [Abstract][Full Text] [Related]
9. 300 mg nizatidine at night versus 300 mg ranitidine at night in patients with duodenal ulcer. A multicentre trial in Europe.
Simon B; Cremer M; Dammann HG; Hentschel E; Keohane PP; Mulder H; Müller P; Sarles H
Scand J Gastroenterol Suppl; 1987; 136():61-70. PubMed ID: 2892257
[TBL] [Abstract][Full Text] [Related]
10. Comparison of famotidine with cimetidine and ranitidine.
Berardi RR; Tankanow RM; Nostrant TT
Clin Pharm; 1988 Apr; 7(4):271-84. PubMed ID: 2896559
[TBL] [Abstract][Full Text] [Related]
11. Continuous intragastric pH monitoring: a real progress in the assessment of antisecretory drugs.
Savarino V
Ital J Gastroenterol; 1990; 22 Suppl 2():20-3. PubMed ID: 1983412
[TBL] [Abstract][Full Text] [Related]
12. Comparison of twice-daily ranitidine with standard cimetidine treatment of duodenal ulcer.
Walt RP; Trotman IF; Frost R; Golding PL; Shepherd TH; Rawlings J; Hunt RH; Colin-Jones D; Milton-Thompson GJ; Misiewicz JJ
Gut; 1981 Apr; 22(4):319-22. PubMed ID: 6113192
[TBL] [Abstract][Full Text] [Related]
13. Effects of three H2-receptor antagonists (cimetidine, famotidine, ranitidine) on serum gastrin level.
Ohsawa T; Hirata W; Higichi S
Int J Clin Pharmacol Res; 2002; 22(2):29-35. PubMed ID: 12503773
[TBL] [Abstract][Full Text] [Related]
14. The 24-hour acid suppression profile of nizatidine.
Dammann HG; Gottlieb WR; Walter TA; Müller P; Simon B; Keohane P
Scand J Gastroenterol Suppl; 1987; 136():56-60. PubMed ID: 2892256
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects of placebo, ranitidine, famotidine and nizatidine on intragastric acidity by means of continuous pH recording.
Savarino V; Mela GS; Zentilin P; Scalabrini P; Bonifacino G; Gambaro P; Celle G
Digestion; 1989; 42(1):1-6. PubMed ID: 2568299
[TBL] [Abstract][Full Text] [Related]
16. Tolerance during 29 days of conventional dosing with cimetidine, nizatidine, famotidine or ranitidine.
Nwokolo CU; Smith JT; Gavey C; Sawyerr A; Pounder RE
Aliment Pharmacol Ther; 1990; 4 Suppl 1():29-45. PubMed ID: 1983345
[TBL] [Abstract][Full Text] [Related]
17. Comparison of ranitidine and cimetidine ulcer maintenance therapy.
Kurata JH; Koch GG; Nogawa AN
J Clin Gastroenterol; 1987 Dec; 9(6):644-50. PubMed ID: 3327884
[TBL] [Abstract][Full Text] [Related]
18. H2-receptor antagonists: development and application.
Feldman S
N Engl Reg Allergy Proc; 1986; 7(4):362-6. PubMed ID: 2886903
[TBL] [Abstract][Full Text] [Related]
19. Response to "H2-receptor antagonists and duodenal ulcer recurrence".
Kurata JH; Nogawa AN; Koch GG
Am J Gastroenterol; 1988 Dec; 83(12):1427-9. PubMed ID: 2904219
[No Abstract] [Full Text] [Related]
20. Determining the optimal dosage regimen for H2-receptor antagonist therapy--a dose validation approach.
Young MD; Frank WO; Dickson BD; Peace KP; Braverman A; Mounce W
Aliment Pharmacol Ther; 1989 Feb; 3(1):47-57. PubMed ID: 2577482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]